Glossary
Definitions of the terms used across the Dr.MaxHealth platform and documentation.
- Biomarker forecasting
- The use of statistical or machine-learning models to project a clinical biomarker from longitudinal history. PULSE presents biomarker trajectories with stated uncertainty and retains the recorded history used for the review.
- Longitudinal blood panel
- A series of blood test results for the same patient collected over time, enabling trend analysis rather than single-point interpretation. Laboratory results are one part of the longitudinal record PULSE can reconstruct for review.
- Patient trajectory intelligence
- Software that represents a patient as an ordered longitudinal record, models how that record is changing over time, and prepares evidence-linked findings for physician review. It augments, but does not replace, clinical judgment.
- Clinical decision support (CDS)
- Software that provides clinicians, staff, or patients with knowledge and person-specific information, intelligently filtered or presented to enhance health and care. PULSE prepares findings that require review by a qualified healthcare professional; it does not diagnose, prescribe, or act on patients.
- Uncertainty band
- A visual representation of the prediction interval around a forecasted value, typically a 80% or 95% interval. Showing uncertainty is a hallmark of clinically responsible AI.
- Retrieval-augmented generation (RAG)
- An AI architecture that grounds language-model outputs in retrieved source documents (guidelines, peer-reviewed literature) to reduce hallucination and produce citation-backed evidence snippets.
- Guideline-linked note
- An evidence-linked finding that retains the relevant source reference so a reviewing physician can inspect the basis for the information presented.
- Calibration curve
- A plot comparing predicted probabilities to observed frequencies. A well-calibrated model's curve sits on the diagonal — essential for trustworthy clinical predictions.
- Mean absolute error (MAE)
- The average magnitude of forecast errors, expressed in the same units as the biomarker. MAE can be included among the metrics agreed for a retrospective forecasting evaluation.
- Data drift
- A change in the statistical properties of input data over time, such as new laboratory assays or population shifts, that may affect model performance and should be considered in evaluation and monitoring design.
- Bias audit
- A systematic evaluation of model performance across subgroups (sex, age, ethnicity, comorbidities) to detect and mitigate inequitable predictions.
- Clinician-in-the-loop
- A workflow design where AI outputs are always reviewed and acted upon by a licensed clinician, preserving accountability and clinical judgment.
- Decision support, not diagnostic
- A regulatory and product-design distinction: Dr.MaxHealth surfaces patterns and evidence to inform a physician's reasoning but does not output a diagnosis or treatment decision.
- DMH Software UG
- DMH Software UG (haftungsbeschränkt) — the German legal entity (Handelsregister HRB 196754, Hamburg) operating the Dr.MaxHealth platform.
- Hamburg, Germany
- The registered seat of DMH Software UG (Klaus-Groth-Strasse 77, 20535 Hamburg). Engagement-specific processing roles and data-protection requirements are documented before patient data is processed.
- GDPR / DSGVO
- The EU General Data Protection Regulation (Datenschutz-Grundverordnung), the regulatory framework governing all processing of patient and user data on the Dr.MaxHealth platform.